Featured Opinions
5 ways to gauge your sales managers coaching
by Steven Rosen
In my last post I told you about my lunch with a VP of sales who was frustrated because the members of his sales management team were focused so exclusively on results that they neglected the care and
Adherence, compliance, persistence, relationship.. No wonder everybody is confused!!!
by Anonymous (not verified)
As you may or may not know, I am currently in the midst of developing the final program for the forthcoming Patient XXXXX Summit USA.
Getting the buzz from patients
by Keith Petrie
One of the early fears about technology is that it would isolate people and erode social relationships, but the reality is just the opposite.
by Anonymous (not verified)
Last week, patientslikeme http://blog.patientslikeme.com/2009/04/15/patientslikeme-offers-adverse-event-reporting-for-ms-patients/, the over 10,000 patient-strong MS online community, started to repor
If I had a dollar for every statistic or research out put that emphasised how much the general public loathed the industry I would be a millionaire.
Twitter and Pharma: Which Companies Tweet the Most?
by Clifford M
Twitter, which is currently de rigueur in social media circles, is emerging as one of the most powerful branding and marketing social media tool that has been developed to date.
Top 10 search terms related to Drugs & Medications in 2008
1. medication 2. lexapro 3. xanax 4. tylenol 5. tramadol 6. zoloft 7. vicodin 8. prozac 9. cymbalta 10. effexor
Top 10 search terms related to Health Conditions in 2008
1. cancer 2. heart 3. skin 4. diabetes 5. hiv 6. breast 7. sleep 8. aids 9. acne 10. thyroid The figures are based on searches performed worldwide on Google.com in 2008
Talking about KAM and Sales Call Quality
by Mark Wayland
Wharton Business School has just published a very interesting paper.
Social Media and Pharma: Issues, opportunities and solutions
As we all know social media can be used by healthcare professionals and the public to talk about a pharmaco's products and brand. But pharmacos, as a general rule, have avoided so
100million wasted medication..just the tip of the ice-berg!
There is an assumption that if a patient keeps turning up to pick up the repeat prescription then this will lead to better outcomes for the patient.
The Social Spider: Giving Your Brand a Lot of Legs
by WendyB
Digital marketing is a far cry from where it was seven, five, or even two years ago. And it continues to evolve at a rapid pace.
How Has Social Media Changed the Way You Live, Work?
by WendyB
On a personal note, I have been thinking a lot lately about how my life has been drastically changed by social technology. Some for better, some for worse, and some of it is just - well - different.
Healthcare and Pharma Social Media: It's All About E.V.E.
No, no, not the 1950 classic "All About Eve [1]" starring Bette Davis. I mean "All About *E.V.E*." [1] http://www.imdb.com/title/tt0042192/
Why Downsizing May Hurt Pharma
by Clifford M
Since 2007, approximately 80,000 pharmaceutical jobs have been eliminated.
U.S. Government Cracks Down on Pharma Marketing
by WendyB
Two major pieces of news emerged over the past week that will likely have far-reaching implications for the way pharmaceutical companies market in the U.S. online.
Patient Adherence: Getting Personal
This week my wife was diagnosed with Type 2 Diabetes, I must say it was a bit of a surprise as she is slim and generally eats quite healthy food.
The downturn spiral - stand your ground
Time to change strategy, focus and tactics, we are in a downturn. Why? Do we really need to make radical changes?
Our sales force are great at exagerrating the benefits of our brands but does this special ability have an impact on us too? Do you believe your sales force?
Pursuing Sales Results vs. Developing Your Team
by Steven Rosen
I recently had lunch with a highly successful VP of Sales. He explained that he was frustrated with the members of his sales management team, who he felt were focused only on results.
FDA Chides 14 Drug Makers for Misleading Internet Ads
by Clifford M
Today's New York Times reported that the US Food and Drug Administration (FDA) issued warning letters and ordered 14 pharmaceutical and biotechnology companies to stop running what it calls misleading
Word on the Street: Novartis May Purchase Cubist for $1.6 billion
by Clifford M
Rumors are rife that Novartis is going to purchase Lexington, MA-based Cubist for $1.6 billion. Wall Street analysts are speculating that Novartis may announce the deal as early as Monday.